BC
Broadfin Capital Portfolio holdings
AUM
$403M
This Quarter Return
+10.14%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$690M
AUM Growth
+$690M
(-3.2%)
Cap. Flow
-$27.3M
Cap. Flow
% of AUM
-3.95%
Top 10 Holdings %
Top 10 Hldgs %
57.65%
Holding
63
New
10
Increased
12
Reduced
21
Closed
11
Top Buys
| 1 |
AERI
Aerie Pharmaceuticals, Inc.
AERI
|
$16.3M |
| 2 |
Alnylam Pharmaceuticals
ALNY
|
$14.5M |
| 3 |
LJPC
La Jolla Pharmaceutical Company
LJPC
|
$14.1M |
| 4 |
CORI
Corium International, Inc.
CORI
|
$12.3M |
| 5 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
$11.7M |
Top Sells
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$19M |
| 2 |
ADXS
Advaxis, Inc.
ADXS
|
$12.4M |
| 3 |
MDCO
Medicines Co
MDCO
|
$10.5M |
| 4 |
ATRS
Antares Pharma, Inc.
ATRS
|
$9.14M |
| 5 |
DURECT Corp
DRRX
|
$8.93M |
Sector Composition
| 1 | Healthcare | 89.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVET
26
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| $7.54M | 0.92% | 1,127,200 | – | – |
|
|
PGNX
27
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $6.79M | 0.82% | 1,000,000 -998,531 | -50% | -$6.78M |
|
|
PRTK
28
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $6.68M | 0.81% | 277,020 +53,158 | +24% | +$1.28M |
|
|
ACGN
29
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $6.63M | 0.81% | 3,852,945 | – | – |
|
30
Cidara Therapeutics
CDTX
$1.66B
| $6.12M | 0.74% | 816,275 +253,400 | +45% | +$1.9M |
|
|
NUVA
31
DELISTED
NuVasive, Inc.
NUVA
| $4.3M | 0.52% | +55,900 | New | +$4.3M |
|
|
NTUS
32
DELISTED
Natus Medical Inc
NTUS
| $4.16M | 0.51% | +111,500 | New | +$4.16M |
|
|
ZGNX
33
DELISTED
Zogenix, Inc.
ZGNX
| $3.81M | 0.46% | +262,500 | New | +$3.81M |
|
|
ELGX
34
DELISTED
Endologix Inc
ELGX
| $3.79M | 0.46% | 779,341 -889,679 | -53% | -$4.32M |
|
|
ARLZ
35
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $2.75M | 0.33% | 2,034,103 -3,157,487 | -61% | -$4.26M |
|
36
ADMA Biologics
ADMA
$4.12B
| $2.52M | 0.31% | 681,346 -347,326 | -34% | -$1.29M |
|
|
CBIO
37
Crescent Biopharma, Inc. Common Stock
CBIO
$200M
| $2.48M | 0.3% | +221,848 | New | +$2.48M |
|
38
iRhythm Technologies
IRTC
$5.46B
| $2.24M | 0.27% | +52,700 | New | +$2.24M |
|
39
Globus Medical
GMED
$8.27B
| $2.21M | 0.27% | +66,700 | New | +$2.21M |
|
|
CFRX
40
DELISTED
ContraFect Corporation
CFRX
| $1.92M | 0.23% | 1,325,356 -103,753 | -7% | -$150K |
|
|
CGNT
41
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.91M | 0.23% | 1,094,544 +340,771 | +45% | +$593K |
|
42
MediWound
MDWD
$182M
| $1.19M | 0.14% | 174,665 -458,437 | -72% | -$3.12M |
|
43
Alphatec Holdings
ATEC
$2.35B
| $1.1M | 0.13% | 594,533 +368,527 | +163% | +$682K |
|
44
Tempest Therapeutics
TPST
$44M
| $429K | 0.05% | +274,853 | New | +$429K |
|
|
DXTR
45
DELISTED
Dextera Surgical Inc.
DXTR
| $296K | 0.04% | 987,520 +388,080 | +65% | +$116K |
|
46
Strata Skin Sciences
SSKN
$9.93M
| $162K | 0.02% | 66,612 -894,810 | -93% | -$2.18M |
|
47
Arcturus Therapeutics
ARCT
$462M
| – | – | -1,216,643 | Closed | -$1.39M |
|
|
48
DURECT Corp
DRRX
$59.6M
| – | – | -8,506,229 | Closed | -$8.93M |
|
49
DexCom
DXCM
$29.5B
| – | – | -49,300 | Closed | -$4.18M |
|
50
Gilead Sciences
GILD
$140B
| – | – | 0 | – | – |
|